281 related articles for article (PubMed ID: 14729474)
21. Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling.
Chakkalakal JV; Stocksley MA; Harrison MA; Angus LM; Deschenes-Furry J; St-Pierre S; Megeney LA; Chin ER; Michel RN; Jasmin BJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7791-6. PubMed ID: 12808150
[TBL] [Abstract][Full Text] [Related]
22. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
23. A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation.
Kim SJ; Ding W; Albrecht B; Green PL; Lairmore MD
J Biol Chem; 2003 May; 278(18):15550-7. PubMed ID: 12601010
[TBL] [Abstract][Full Text] [Related]
24. Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation.
Larrieu D; Thiébaud P; Duplàa C; Sibon I; Thézé N; Lamazière JM
Exp Cell Res; 2005 Oct; 310(1):166-75. PubMed ID: 16129432
[TBL] [Abstract][Full Text] [Related]
25. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation.
Abbasi S; Su B; Kellems RE; Yang J; Xia Y
J Biol Chem; 2005 Nov; 280(44):36737-46. PubMed ID: 16126726
[TBL] [Abstract][Full Text] [Related]
26. Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice.
Parsons SA; Wilkins BJ; Bueno OF; Molkentin JD
Mol Cell Biol; 2003 Jun; 23(12):4331-43. PubMed ID: 12773574
[TBL] [Abstract][Full Text] [Related]
27. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
28. Remodeling muscles with calcineurin.
Olson EN; Williams RS
Bioessays; 2000 Jun; 22(6):510-9. PubMed ID: 10842305
[TBL] [Abstract][Full Text] [Related]
29. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
[TBL] [Abstract][Full Text] [Related]
30. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type.
Chin ER; Olson EN; Richardson JA; Yang Q; Humphries C; Shelton JM; Wu H; Zhu W; Bassel-Duby R; Williams RS
Genes Dev; 1998 Aug; 12(16):2499-509. PubMed ID: 9716403
[TBL] [Abstract][Full Text] [Related]
31. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.
Liang Q; Bueno OF; Wilkins BJ; Kuan CY; Xia Y; Molkentin JD
EMBO J; 2003 Oct; 22(19):5079-89. PubMed ID: 14517246
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes.
Suzuki E; Nishimatsu H; Satonaka H; Walsh K; Goto A; Omata M; Fujita T; Nagai R; Hirata Y
Circ Res; 2002 May; 90(9):1004-11. PubMed ID: 12016267
[TBL] [Abstract][Full Text] [Related]
33. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription.
Wada H; Hasegawa K; Morimoto T; Kakita T; Yanazume T; Abe M; Sasayama S
J Cell Biol; 2002 Mar; 156(6):983-91. PubMed ID: 11889139
[TBL] [Abstract][Full Text] [Related]
34. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
[TBL] [Abstract][Full Text] [Related]
35. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
[TBL] [Abstract][Full Text] [Related]
36. NFAT: ubiquitous regulator of cell differentiation and adaptation.
Horsley V; Pavlath GK
J Cell Biol; 2002 Mar; 156(5):771-4. PubMed ID: 11877454
[TBL] [Abstract][Full Text] [Related]
37. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.
Diedrichs H; Chi M; Boelck B; Mehlhorn U; Schwinger RH
Eur J Heart Fail; 2004 Jan; 6(1):3-9. PubMed ID: 15012912
[TBL] [Abstract][Full Text] [Related]
38. Regulation of myosin heavy chain expression during rat skeletal muscle development in vitro.
Torgan CE; Daniels MP
Mol Biol Cell; 2001 May; 12(5):1499-508. PubMed ID: 11359938
[TBL] [Abstract][Full Text] [Related]
39. Calcineurin signaling and neural control of skeletal muscle fiber type and size.
Schiaffino S; Serrano A
Trends Pharmacol Sci; 2002 Dec; 23(12):569-75. PubMed ID: 12457775
[TBL] [Abstract][Full Text] [Related]
40. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
